This is further evidenced by the factor that a miR155-5p inhibitor can attenuate the effect on SIRT1 and subsequently inhibit EMT, thus surpressing the polyposogenesis of CRSwNP. The gene discussed is SIRT1; the disease is chronic rhinosinusitis with nasal polyps.